Biovista profiled in latest Insight Pharma report “Drug Repositioning:Extracting Added Value from Prior R&D Investments”.
Read More…Drug repositioning is also known as drug repurposing, reprofiling, or retasking. In “on-target repurposing,” a drug’s known pharmacological mechanism is applied to a different therapeutic indication than that for which it was initially developed. Even more innovative is “off-target repurposing, ” which looks for pharmacological mechanisms that have not yet been described for a known molecule. In either case, having previously failed during clinical development is not a criterion for repositioning; the avenue is equally open to drugs that are or have been marketed.
…